The antibody clones include the reagents used for studying macrophage subsets in rats, the ‘ED series’ of antibodies.
The agreementis expected to strengthen AbD Serotec’s position as primary source of reagents for studying the innate immune system.
AbD Serotec head Dieter Feger said that they have decided to further expand their offering in innate immunity research and take an exclusive manufacturing license for a range of ED antibody clones from the VU University Medical Center.